Thalix
Formulated to alleviate symptoms of multiple myeloma to support patient stabilization.
- Category
- Oncology Support
- Active ingredient
- Thalidomide
- Supply
- Rx
- Route
- Oral use
- Form
- Capsule, hard
- Strengths
- 50 · 100mg
Thalix details
- Condition
- Multiple Myeloma
- Therapeutic class
- Immunomodulator
- Pharmacological class
- Thalidomide analogue
- Minor side effects
- somnolence; dizziness; peripheral oedema; constipation
- Moderate side effects
- peripheral neuropathy; neutropenia
- Dosage forms
- Capsule, hard
- Administration route
- Oral use
- Supply category
- Prescription only (specially controlled medicine)
- Manufacturer
- Natco Pharma
- Onset Time
- 3–4 hours
- Duration
- 24 hours
- Storage instructions
- Store in a safe location and return unused capsules to the pharmacy.
- Drug interactions
- hormonal contraceptives; alcohol; sedatives
- Age restrictions
- Not for use in children.
Contraindications
pregnancy; women of childbearing potential unless strict contraceptive measures exist; severe hypersensitivity
Precautions and warnings
requires participation in a mandatory pregnancy prevention programme; monitor for peripheral neuropathy; risk of thrombotic events
Serious side effects
teratogenicity, requires immediate medical attention; venous thromboembolism, requires immediate medical attention
Patient summary
formulated to alleviate symptoms of multiple myeloma to support patient stabilization.
Mechanism of action
The drug exerts immunomodulatory, anti-inflammatory, and anti-angiogenic properties. It alters cytokine production, specifically inhibiting tumour necrosis factor-alpha, and restricts the growth of new blood vessels supplying tumour cells.
Pregnancy and breastfeeding
Pregnancy: Absolute contraindication due to high risk of severe birth defects. Breastfeeding: Not recommended.
Where this medicine is registered
- Singapore
- Hong Kong
- Thailand
- Malaysia
- Philippines
- Indonesia
- Taiwan
- South Korea
- Japan
- Australia
- New Zealand
- UAE
- South Africa
About Thalix
Thalix contains thalidomide, an active ingredient used to address the effects of multiple myeloma. Manufactured by Natco Pharma, this medication is supplied as a capsule in 50mg and 100mg strengths. It is a well-recognised treatment option for patients who require this specific therapy as part of their health management plan.
Thalix availability in Asia
Thalidomide is registered for use across 13 markets, including Hong Kong, Thailand and Malaysia, with availability extending to the Philippines, Indonesia and Taiwan. Generic thalidomide options commonly provide a more affordable alternative to original brand versions for residents and expats living across these regions. Because of the specific nature of this treatment, it is best used under the direct care and supervision of a doctor.